ERBB2 and neoplasm: However, we feel that tumour ErbB2-IR has limited value as a clinical marker to aid treatment decisions, for three reasons: firstly, its magnitude is limited given that the area under the ROC curve, albeit significant, is a meagre 0.60 (values ≤0.75 have been described as “not clinically useful” [32]).